LWCFA
Loring Wolcott & Coolidge Fiduciary Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $52.5M | Buy |
99,913
+3,440
| +4% | +$1.81M | 0.46% | 44 |
|
|
2025
Q1 | $56.7M | Sell |
96,473
-9,618
| -9% | -$5.65M | 0.55% | 42 |
|
|
2024
Q4 | $72.6M | Sell |
106,091
-3,390
| -3% | -$2.32M | 0.62% | 37 |
|
|
2024
Q3 | $102M | Buy |
109,481
+5,801
| +6% | +$5.39M | 0.91% | 32 |
|
|
2024
Q2 | $114M | Buy |
103,680
+16,406
| +19% | +$18M | 1.05% | 29 |
|
|
2024
Q1 | $78.6M | Buy |
87,274
+25,828
| +42% | +$23.2M | 0.78% | 35 |
|
|
2023
Q4 | $57.9M | Buy |
61,446
+17,529
| +40% | +$16.5M | 0.57% | 41 |
|
|
2023
Q3 | $36M | Buy |
43,917
+27,181
| +162% | +$22.3M | 0.4% | 49 |
|
|
2023
Q2 | $12M | Buy |
16,736
+4,016
| +32% | +$2.89M | 0.13% | 66 |
|
|
2023
Q1 | $10.5M | Buy |
12,720
+123
| +1% | +$101K | 0.12% | 66 |
|
|
2022
Q4 | $9.09M | Buy |
12,597
+663
| +6% | +$478K | 0.11% | 67 |
|
|
2022
Q3 | $8.22M | Buy |
11,934
+929
| +8% | +$640K | 0.11% | 67 |
|
|
2022
Q2 | $6.51M | Buy |
11,005
+92
| +0.8% | +$54.4K | 0.08% | 76 |
|
|
2022
Q1 | $7.62M | Buy |
10,913
+71
| +0.7% | +$49.6K | 0.08% | 77 |
|
|
2021
Q4 | $6.85M | Buy |
10,842
+135
| +1% | +$85.3K | 0.06% | 84 |
|
|
2021
Q3 | $6.48M | Buy |
10,707
+22
| +0.2% | +$13.3K | 0.06% | 80 |
|
|
2021
Q2 | $5.97M | Buy |
10,685
+550
| +5% | +$307K | 0.06% | 81 |
|
|
2021
Q1 | $4.8M | Buy |
10,135
+9,975
| +6,234% | +$4.72M | 0.05% | 87 |
|
|
2020
Q4 | $77K | Buy |
+160
| New | +$77K | ﹤0.01% | 382 |
|
|
2018
Q2 | – | Sell |
-345
| Closed | -$119K | – | 719 |
|
|
2018
Q1 | $119K | Sell |
345
-400
| -54% | -$138K | ﹤0.01% | 345 |
|
|
2017
Q4 | $280K | Hold |
745
| – | – | 0.01% | 245 |
|
|
2017
Q3 | $333K | Buy |
745
+500
| +204% | +$223K | 0.01% | 231 |
|
|
2017
Q2 | $120K | Hold |
245
| – | – | ﹤0.01% | 338 |
|
|
2017
Q1 | $95K | Hold |
245
| – | – | ﹤0.01% | 356 |
|
|
2016
Q4 | $90K | Hold |
245
| – | – | ﹤0.01% | 342 |
|
|
2016
Q3 | $98K | Hold |
245
| – | – | ﹤0.01% | 336 |
|
|
2016
Q2 | $86K | Hold |
245
| – | – | ﹤0.01% | 337 |
|
|
2016
Q1 | $88K | Hold |
245
| – | – | ﹤0.01% | 324 |
|
|
2015
Q4 | $133K | Hold |
245
| – | – | ﹤0.01% | 309 |
|
|
2015
Q3 | $125K | Hold |
245
| – | – | ﹤0.01% | 331 |
|
|
2015
Q2 | $125K | Buy |
245
+60
| +32% | +$30.6K | ﹤0.01% | 331 |
|
|
2015
Q1 | $84K | Buy |
185
+85
| +85% | +$38.6K | ﹤0.01% | 382 |
|
|
2014
Q4 | $41K | Buy |
+100
| New | +$41K | ﹤0.01% | 448 |
|